Oxcarbazepine for trigeminal neuralgia may induce lower extremity weakness: A case report

doi:10.12998/wjcc.v8.i5.922

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10176)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

313

WORD

195

HTML

6098

Figures (1-1)

313

Tables (1-1)

315

Sum=7234

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

532

Download

714

Sum=1246

Publishing Process of This Article

Item

Count

Browse

727

Download

969

Sum=1696

Mar 6, 2020 (publication date) through Dec 18, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Mar 6, 2020; 8(5): 922-927
Published online Mar 6, 2020. doi: 10.12998/wjcc.v8.i5.922

Full Size Figure Download Figure

Figure 1 Change of sodium levels after discontinuation of oxcarbazepine. Na: Sodium; OXC: Oxcarbazepine; VAS: Visual analogue scale.

Citation: Song HG, Nahm FS. Oxcarbazepine for trigeminal neuralgia may induce lower extremity weakness: A case report. World J Clin Cases 2020; 8(5): 922-927
URL: https://www.wjgnet.com/2307-8960/full/v8/i5/922.htm
DOI: https://dx.doi.org/10.12998/wjcc.v8.i5.922